Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

368
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
368
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

672
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
672
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LLM-Driven Regime-Adaptive strategy synthesis for Polymorphic Network routing.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Bridging graph structure and knowledge-guided editing for interpretable temporal knowledge graph reasoning.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Searching to Modulate for Cold-Start Recommendation.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Slack Federated Adversarial Training.

IEEE transactions on pattern analysis and machine intelligence·2025
Same author

Robust heterogeneous network representation learning by multifaceted curriculum training.

Neural networks : the official journal of the International Neural Network Society·2025
Same author

KnowFlow: Empowering decision-making on networks with knowledge-streamlined agent.

Neural networks : the official journal of the International Neural Network Society·2025

Related Experiment Video

Updated: Jun 29, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning.

Yaqing Wang1, Zaifei Yang1,2, Quanming Yao3

  • 1Baidu Research, Baidu Inc., Beijing, China.

Communications Medicine
|March 29, 2024
PubMed
Summary

KnowDDI, a novel graph neural network method, improves drug-drug interaction (DDI) prediction by leveraging biomedical knowledge graphs. It effectively compensates for rare known DDIs using enriched drug representations and propagated similarities, achieving state-of-the-art results.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

Related Experiment Videos

Last Updated: Jun 29, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

Area of Science:

  • Computational biology
  • Pharmacology
  • Artificial intelligence

Background:

  • Predicting drug-drug interactions (DDIs) is crucial but challenging due to the rarity of known interactions.
  • Existing deep learning methods for DDI prediction often require extensive data, which is a limitation given the scarcity of known DDIs.

Purpose of the Study:

  • To develop a novel graph neural network-based method, KnowDDI, for accurate and interpretable drug-drug interaction prediction.
  • To address the challenge of limited known DDIs by enhancing drug representations and utilizing biomedical knowledge graphs.

Main Methods:

  • KnowDDI employs a graph neural network architecture to enhance drug representations by integrating information from large biomedical knowledge graphs.
  • It constructs a knowledge subgraph for each drug pair to interpret predicted DDIs, with edge strengths indicating interaction importance or similarity.
  • The method implicitly compensates for the lack of known DDIs through enriched drug representations and propagated drug similarities.

Main Results:

  • KnowDDI achieved state-of-the-art prediction performance on two benchmark DDI datasets.
  • The method demonstrated improved interpretability in predicting DDIs.
  • KnowDDI showed greater resilience to sparser knowledge graphs compared to existing methods, highlighting the importance of propagated drug similarities.

Conclusions:

  • KnowDDI effectively integrates deep learning efficiency with the rich knowledge from biomedical graphs for DDI prediction.
  • As an open-source tool, KnowDDI can be applied to various interaction prediction tasks, advancing biomedicine and healthcare.
  • The approach demonstrates the utility of leveraging external knowledge to overcome data limitations in predictive modeling.